Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer Dec 8, 2016 A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.
NSABP B52 trial shows estrogen deprivation in neoadjuvant chemotherapy breast cancer treatment is not antagonistic to pathologic complete response Dec 8, 2016 Research by Dr. Mothaffar F. Rimawi he finds that adding an aromatase inhibitor to presurgery breast cancer treatment did not significantly increase or decrease the percentage of patients who experienced a pathologic complete response.
Scientists can now better diagnose diseases with multiple genetic causes Dec 7, 2016 Scientists are combining descriptions of patients’ clinical features with their complex genetic information in a unified analysis to obtain more precise diagnoses of complex diseases.
Dr. Meng Wang honored with 2017 Edith and Peter O’Donnell Award Dec 7, 2016 Dr. Meng Wang has been awarded the 2017 Edith and Peter O’Donnell Award in Medicine, recognizing her as a rising star researchers in Texas.
Scientists find persistent infections in mice exhaust progenitors of all blood cells; potential treatment possible Dec 6, 2016 Mouse model reveal that long-lasting infections trigger the loss of progenitors of blood cells and suggest a strategy that may help prevent or treat this condition in the future.
Study to investigate connection between antibiotic use and autism symptoms Dec 1, 2016 Baylor College of Medicine is launching a study that will investigate why some children with autism spectrum disorder experience changes in their autism symptoms when taking antibiotics.
Disturbing circadian rhythm connected to higher risk of liver cancer in mice; link to humans Nov 23, 2016 A team of researchers says disrupting a regular sleep routine can trigger the development of liver cancer in mice.
CPRIT awards Baylor College of Medicine additional $7 million to individual investigators Nov 21, 2016 Researchers at Baylor College of Medicine have received over $7 million from the Cancer Prevention and Research Institute of Texas (CPRIT) for seven new grants.
New synthetic protein captures DNA events leading to cancer, opens possibilities for improved cancer therapies Nov 18, 2016 Researchers identify opportunities for developing new drugs to neutralize molecular intermediates before they lead to cancer.
Unraveling what happens inside a tumor; new method opens opportunities to improve diagnosis and treatment Nov 17, 2016 New strategy allows researchers to identify the different types of cells in the tumor and to unveil how the interactions between cancer and normal cells may shape the fate of the tumor.